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Aim To assess the relationship between corrected QT (QTc) 
interval and vitamin 25-hydroxyvitamin D levels (25-OHD) 
deficiency in type 2 diabetic patients.
Methods The study included 253 patients with type 2 di-
abetes and 170 age-matched controls treated between 
October and December 2013. QTc duration and QTc dis-
persion were measured on ECG recordings and 25-OHD, 
calcium, phosphorus, and blood glucose levels were de-
termined.
Results Patients with diabetes had significantly longer QTc 
duration and QTc dispersion than controls (P < 0.001 and 
P < 0.001 respectively). Diabetic patients with prolonged 
QTc duration were older and had longer diabetes duration 
and higher HbA1c levels than patients with normal QTc in-
terval. They significantly more frequently had 25-OHD de-
ficiency (P < 0.001), but had similar calcium and phospho-
rus levels. Diabetic patients with prolonged QTc dispersion 
were of similar age and had similar diabetes duration 
and HbA1c levels as patients with normal QTc dispersion. 
They significantly more frequently had 25-OHD deficiency 
(P = 0.010), but had similar calcium and phosphorus levels.
Conclusion This study showed prolonged QTc duration 
and QTc dispersion in patients with type 2 diabetes, espe-
cially those with 25-OHD deficiency.
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Worldwide prevalence of type 2 diabetes mellitus (T2DM) is 
7.7%, and is expected to further increase. The principal cause 
of death in patients with T2DM are cardiovascular diseases, 
with the annual mortality of 5.4% (1). Cardiac mortality and 
morbidity rate can be reduced by disease detection at the 
time when overt cardiac disease is still not present. This re-
quires novel screening strategies, one of which is QT interval 
analysis. QT abnormalities can predict cardiac death in sev-
eral diseases, including chronic heart failure, systemic hyper-
tension, and peripheral vascular disease (2). In diabetic pa-
tients QT abnormalities can be detected at diagnosis and are 
better predictors of cardiac death than autonomic function 
tests (3). Moreover, in diabetic patients increased QT disper-
sion was shown to predict cardiovascular mortality (4).
Calcium-phosphorus metabolism disorders and 25 hy-
droxyvitamin D (25-OHD) deficiency are known risk fac-
tors for cardiovascular events (5-7). Also, disturbances that 
lead to decreased 25-OHD levels have been shown to re-
sult in structural and ionic channel remodeling, which may 
increase the susceptibility to cardiac arrhythmias. In addi-
tion, they induce cardiac hypertrophy and fibrosis, which 
are known risk factors for sudden cardiac death (7,8).
Altered 25-OHD and calcium homeostasis may also play 
a role in the development of T2DM. Vitamin D has been 
shown to affect the synthesis and secretion of insulin (9) 
and predict the increased risk of all-cause and cardiovas-
cular mortality in T2DM patients independent of conven-
tional risk factors (10). However, there are limited data on 
the relationship between 25-OHD and QT parameters in 
diabetic patients. The aim of this study was to investigate 
the relationship between the 25-OHD deficiency and the 
corrected QT (QTc) interval duration and dispersion in pa-
tients with diabetes.
PaTienTs anD MeThODs
The study included 253 (129 women) consecutive patients 
with type 2 diabetes (mean age of 59.7 years and standard 
deviation [SD], 6.5), followed and treated at our outpatient 
clinic between October and December 2013. The control 
group included 170 (87 women) healthy volunteers (mean 
age of 59.1 years and SD 5.5) who attended their routine 
check-ups at our clinic.
Vitamin D deficiency was defined as 25-OHD concentra-
tion of less than 30 mg/mL (11). Patients who were treat-
ed with vitamin D and calcium within one year before 
the study were not included. We determined partici-
pants’ characteristics including age, duration of diabetes, 
and hypertension, medications, and presence of compli-
cations including retinopathy, nephropathy, and periph-
eral neuropathy. Retinopathy was diagnosed by an oph-
thalmologist and microalbuminuria was defined as urine 
albumin to creatinine ratio between 30 and 300 mg/g. Pe-
ripheral neuropathy was diagnosed on the basis of neuro-
pathic symptoms and signs or objectively abnormal results, 
including insensitivity to a 10 g monofilament, abnormal 
vibration perception threshold, using a thensiometer, and a 
lack of any other and lack of other significant disease (12).
Patients with known coronary artery disease, defined as the 
history of myocardial infarction (MI), coronary artery bypass 
grafting surgery, percutaneous coronary intervention, and 
the presence of coronary heart disease, as documented by 
coronary angiography, were not included in study. Patients 
with chronic renal failure, macroalbuminuria, and acute ill-
ness 24 hours prior testing were also not included. None of 
the patients were receiving drugs that could lengthen the 
QT interval, such as class IA, IC, or III antiarrhtymic drugs. 
Patients with complete bundle branch block, atrial fibril-
lation, second or third degree atrio-ventricular block, or 
less than six measurable leads in the ECG and patients with 
insulin treatment were excluded. All patients were taking 
oral hypoglycemic agents. The study was approved by the 
ethics committee of the Bayindir Hospital and all patients 
provided written informed consent.
ECG was performed with the patients lying comfortably in 
supine position. Digital 12-lead ECG recordings were ana-
lyzed at an ECG paper speed of 25 mm/s using a M1171A 
Pagewritter 200 (Philips, Andover, MA, USA). The QT inter-
vals for each lead were measured manually from the first 
deflection of the QRS complex to the point of the T wave 
offset, defined by the return of the terminal T wave to the 
isoelectric TP baseline. Each QT interval was corrected for 
patient’s heart rate using Bazett’s formula: QTc = QT√RR 
(ms) (13), where QTc >440 ms was considered prolonged. 
QTc dispersion was calculated using the difference be-
tween the maximum and the minimum QTc in any lead. 
QT dispersion >80 ms was considered prolonged.
Blood samples were collected after an overnight fasting 
from the medial cubital vein. Serum calcium and phos-
phorus were measured with photometric system (Roche 
Cobas C501, Roche Diagnostics, Indianapolis, IN, USA). 25-
OHD and hemoglobin A1c (HbA1c) were measured by 
turbidimetric inhibition immunoassay (Roche Cobas C51, 
Roche Diagnostics).
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Data were analyzed by IBM Statistics for Windows, version 
21.0 8 (IBM Corp., Armonk, NY, USA). Normality of the dis-
tribution was tested with Kolmogorov-Smirnov test. Con-
tinuous data were expressed as mean±SD and median with 
interquartile ranges when appropriate. t test and Mann-
Whitney-U test, depending on the normality of distribu-
tion, were used to test the differences between the study 
groups. χ2 test was used for the categorical variables. Logis-
tic regression analyses (stepwise, forward) were used to es-
timate odds ratios (ORs) and the 95% confidence intervals 
(95% CIs). In the regression model, the QTc prolongation 
was entered as dependent variable, and age, duration of di-
abetes and vitamin D deficiency as independent variables. 
Post hoc analysis was performed, and the power of the 
study with given sample size was 0.91 (two means t test). A 
two-tailed P value of 0.050 was considered significant.
ResulTs
Mean duration of diabetes was 9.6 ± 6.6 years. Mean 
HbA1c level was 7.1 ± 1.1% (54 mmol/mol) and median 
fasting blood glucose level was 133 (IQR 111-164) mg/dL. 
Retinopathy was present in 85 (33.5%), neuropathy in 73 
(28.8%), microalbuminuria in 75 (26.9%), and hypertension 
in 108 patients (42.6%) (Table 1).
There was no significant difference in calcium (P = 0.670), 
phosphorus (P = 0.090), 25-OHD levels (P = 0.480), and 
the frequency of 25-OHD deficiency (P = 0.950) between 
the the diabetic group and controls. 25-OHD deficien-
cy was found in 65.2% of patients and 64.7% of controls 
(P = 0.954). Men and women also did not significantly differ 
in the prevalence of 25-OHD deficiency (P = 0.721), QTc du-
ration (P = 0.910), and QTc dispersion (P = 0.760).
Median QTc duration in patients with diabetes was 434 
ms (IQR 418-467) and in controls 423 ms (IQR 403-434) 
(P < 0.001). A prolonged QTc interval was found in 26.8% (68 
in 253) of patients and 4.1% (7 in 170) of controls (P < 0.001). 
In diabetic group, patients with prolonged QTc interval 
more frequently had 25-OHD deficiency than patients 
with normal QTc (P < 0.001). There were no significant dif-
ferences between these groups in calcium and phospho-
rus levels (P = 0.114 and P = 0.752, respectively) (Table 2). In 
multivariate regression analysis the odds of prolonged QTc 
intervals increased significantly with age (P = 0.008), lon-
TaBle 1. Demographic and laboratory data of patients and controls*
Diabetes mellitus patients (n = 253) Controls (n = 170) P†
Age, years (mean ± SD) 59.7 ± 6.5 59.1 ± 5.5 0.518
Sex, female/male 129/124 87/83 0.735
BMI, kg/m˛ (mean ± SD) 30.1 ± 6.8 28.5 ± 7.2 0.073
Fasting glucose, mg/dL (median, IQR) 133, 115.2-163.8 90.9, 85.8-93.78 <0.001
Calcium, mg/dL 9.6 ± 0.3 9.5 ± 0.3 0.670
Phosphorus, mg/dL 3.6 ± 0.5 3.4 ± 0.3 0.090
25 (OH) D deficiency, n (%) 165 (65.4) 110 (64.7) 0.954
QTc interval, ms (median, IQR) 434, 418-467 423, 403-434 <0.001
QTc dispersion, ms (median, IQR) 53.8, 41-72.5 43.2, 31.9-53.9 <0.001
*sD – standard deviation; iQR – interquartile range; 25(Oh)D – 25-hydroxyvitamin D; BMi – body mass index; QTc – corrected QT interval.
†t test or Mann-Whitney u test.
TaBle 2. laboratory data of diabetic patients according to their QTc interval*
Prolonged QT interval 
(QT>440 ms) (n = 68)
normal QT interval 
(QT<440 ms) (n = 185) P†
Age, years (mean ± SD) 61.5 ± 6.6 59.0 ± 6.4 0.012
Sex, female/male 23/25 50/54 0.910
Duration of diabetes, years (median, IQR) 10, 5-17 8, 5-12 0.041
Fasting blood glucose, mg/dL (median, IQR) 136.2, 111.6-181.8 132.8, 110.3-169.2 0.195
HbA1c, % (mean ± SD) 7.4 ± 1.19 7.05 ± 1.09 0.011
Calcium, mg/dL (mean ± SD) 9.4 ± 0.3 9.6 ± 0.4 0.114
Phosphorus, mg/dL (mean ± SD) 3.7 ± 0.7 3.6 ± 0.4 0.752
25 (OH) D deficiency, n (%) 58 (85.2) 104 (56.2) <0.001
*sD – standard deviation; iQR – interquartile range; 25(Oh)D – 25-hydroxyvitamin D; hba1c –hemoglobin a1c; QTc – corrected QT interval.
†t test or Mann-Whitney u test.
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ger duration of diabetes (P = 0.012), higher HbA1c levels 
(P = 0.034), and vitamin D deficiency (P = 0.010) (Table 3). 
The model explained 80.9% of QTc duration. The presence 
of microalbuminuria (P = 0.347), neuropathy (P = 0.126), 
retinopathy (P = 0.310), and hypertension (P = 0.172) were 
similar in both groups.
The median QTc dispersion was 53.8 ms (IQR 41-72.5) in 
patients and 43.2 ms (IQR 31.9-53.9) in controls (P < 0.001). 
Prolonged QTc dispersion was detected in 20.9% of pa-
tients and 4.1% of controls (P < 0.001). Diabetic patients 
with prolonged QTc dispersion were of similar age and 
had similar HbA1c level and diabetes duration as patients 
with normal QTc dispersion. However, they significantly 
more frequently had 25-OHD deficiency (P = 0.010). There 
were no significant differences in calcium and phospho-
rus levels (P = 0.133 and P = 0.217 respectively), microal-
buminuria (P = 0.173), neuropathy and retinopathy inci-
dence (P = 0.376 and P = 0.832 respectively) between these 
groups (Table 4).
DisCussiOn
This study showed prolonged QTc interval and QTc dis-
persion in type 2 diabetic patients. Prolonged QTc interval 
was more frequent in older patients with higher HbA1c 
levels, longer diabetes duration, and 25-OHD deficiency. 
This is the first study that showed the association between 
QTc duration, dispersion, and 25-OHD deficiency in dia-
betic patients.
Although the best characterized sequels of 25-OHD de-
ficiency affect the musculoskeletal system, the discovery 
that most tissues and many cells in the body have a vita-
min D receptor has provided a new insight into the vita-
min D metabolism. It was shown that the vitamin D axis 
affected vascular smooth muscle cell proliferation, inflam-
mation, vascular calcification, renin angiotensin system, 
and blood pressure (14,15), all of which increase the risk of 
coronary vascular disease coronary vascular disease (CVD) 
and MI. In addition, vitamin D regulates calcium and phos-
phorus metabolism, and abnormalities in serum calcium 
concentrations affect QT interval duration (16).
QTc duration and QTc dispersion are the most frequently 
used parameters in the electrocardiographic assessment 
of ventricular repolarization. They have been associated 
with the risk of arrhythmogenesis. They have also been 
shown to be prolonged in diabetic patients (17,18). The 
prevalence of prolonged QTc has been reported to be as 
high as 16% in type 1 diabetes (19) and 30.1% in T2DM 
(20). The prevalence of prolonged QTc interval in our co-
hort was 26.8% and that of prolonged QTc dispersion was 
20.9%. Another study found that QT interval in general 
population was inversely associated with serum calcium 
and positively associated with serum phosphorus, but 
there was no association with 25-OHD (21). In our diabetic 
cohort, prolonged QTc interval and dispersion were asso-
ciated with vitamin 25-OHD deficiency, but not with cal-
cium and phosphorus levels. Calcium plays an important 
role in determining the duration of the action potential 
of cardiac cells. It is well known that hypocalcemia pro-
longs QT interval due to longer phase 2 of the cardiac ac-
tion potential (16). However in our study, patients with 25-






Age 1.03-1.25 1.14 0.008
Duration of diabetes 1.02-1.21 1.11 0.012
HbA1c 1.03-3.18 1.81 0.034
25 (OH) D deficiency 1.44-22.61 5.71 0.010
*25(Oh)D – 25-hydroxyvitamin D; hba1c – hemoglobin a1c; QTc – cor-
rected QT interval.
TaBle 4. laboratory data of the patients according to QTc dispersion*
Prolonged QTc dispersion 
(QTc >80 ms) (n = 53)
normal QTc dispersion 
(QTc <80 ms) (n = 200) P†
Age, years (mean ± SD) 60.5 ± 6.0 59.5 ± 6.7 0.182
Sex, female/male 18/19 56/60 0.764
Duration of diabetes, years (median, IQR) 9.5, 5-15.7 9, 5-12 0.600
Fasting blood glucose, mg/dL (median, IQR) 146.7, 109.8-183 140.7, 110.8-162.7 0.592
HbA1c (mean ± SD) 7.4 ± 1.1 7.0 ± 1.0 0.153
Calcium, mg/dL (mean ± SD) 9.4 ± 0.3 9.6 ± 0.3 0.133
Phosphorus, mg/dL (mean ± SD) 3.7 ± 0.7 3.6 ± 0.4 0.217
25 (OH) D deficiency, n (%) 43 (81.1) 112 (56) 0.010
*sD – standard deviation; iQR – interquartile range; 25(Oh)D – 25-hydroxyvitamin D; hba1c – hemoglobin a1c; QTc – corrected QT interval.
†t test or Mann-Whitney u test.
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OHD deficiency, although they had similar calcium levels 
as controls, had prolonged QTc interval. We may specu-
late that low 25-OHD levels may have an additional effect 
on the pathogenesis of prolonged QTc interval in patients 
with diabetes.
We also observed that patients with prolonged QTc in-
terval had longer diabetes duration and higher HbA1c. 
Acute hyperglycemia has been shown to increase QT in-
terval in newly diagnosed T2DM patients (22). The mecha-
nisms involved in this process were increased intracellular 
calcium concentration and the impairment of sympatho-
vagal balance (22). Additionally, hyperglycemia has been 
demonstrated to increase the sympathetic activity, which 
is evident as increased plasma cathecholamine produc-
tion (23). In our cohort, prolonged QTc interval was also 
associated with age, but prolonged QTc dispersion was 
not. Mangoni et al (24) reported similar observations in 
healthy participants, explaining that they might be sec-
ondary to cardiac hypertrophy and myocardial action po-
tential prolongation.
In our study, QTc duration and dispersion were linearly re-
lated. However, 34% of patients with normal QTc disper-
sion had a prolonged QTc interval. It was reported that 
QTc interval and QTc dispersion may reflect different as-
pects of abnormal ventricular repolarization (3). Our co-
hort comprised T2DM patients and in these patients 
several disease processes may influence myocardial de-
polarization and repolarization duration. Nevertheless, we 
found that 25-OHD deficiency prolonged both QTc inter-
val and QTc dispersion.
25-OHD deficiency is highly prevalent in Turkey and world-
wide (25,26). Its principal causes are limited cutaneous 
synthesis due to inadequate sun exposure or pigmented 
skin and cultural practices. The prevalence of 25-OHD de-
ficiency in Turkey in the summer season is 60% (26), while 
the prevalence observed in our study, conducted in winter, 
was 65.2% in patients and 64.7% in controls. To avoid the 
effect of seasonal changes this study was performed be-
tween October and December.
The main limitation of this study is the manual assessment 
of the QTc interval and dispersion. However, superiority of 
available automatic methods has not been proven (27). 
Also, this study included patients who are receiving oral 
hypoglycemic therapy and without known cardiovascular 
disease, who are not representative of the overall type 2 
diabetic population.
Despite these limitations, this study clearly demonstrated 
the relationship between 25-OHD deficiency and QTc pa-
rameters in diabetic patients. Assessment of 25-OHD levels 
in these patients may be important for better stratification 
of cardiac disease risk. However, these findings need to be 
confirmed by additional randomized trials as well as treat-
ment studies.
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